Williams KJ - Search Results

1

Rapid regression of atherosclerosis: insights from the clinical and experimental literature.

Williams KJ, Feig JE, Fisher EA. Williams KJ, et al. Nat Clin Pract Cardiovasc Med. 2008 Feb;5(2):91-102. doi: 10.1038/ncpcardio1086. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18223541 Review.

2

The unstirred water layer as a site of control of apolipoprotein B secretion.

Williams KJ, Brocia RW, Fisher EA. Williams KJ, et al. J Biol Chem. 1990 Oct 5;265(28):16741-4. J Biol Chem. 1990. PMID: 2170353 Free article.

3

UVB irradiation alters cellular responses to cytokines: role in extracellular matrix gene expression.

Werth VP, Williams KJ, Fisher EA, Bashir M, Rosenbloom J, Shi X. Werth VP, et al. Among authors: williams kj. J Invest Dermatol. 1997 Mar;108(3):290-4. doi: 10.1111/1523-1747.ep12286462. J Invest Dermatol. 1997. PMID: 9036927 Free article.

4

The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Fuki IV, Kuhn KM, Lomazov IR, Rothman VL, Tuszynski GP, Iozzo RV, Swenson TL, Fisher EA, Williams KJ. Fuki IV, et al. Among authors: williams kj. J Clin Invest. 1997 Sep 15;100(6):1611-22. doi: 10.1172/JCI119685. J Clin Invest. 1997. PMID: 9294130 Free PMC article.

5

Atherosclerosis: cell biology and lipoproteins--three distinct processes that control apolipoprotein-B secretion.

Williams KJ, Fisher EA. Williams KJ, et al. Curr Opin Lipidol. 2001 Apr;12(2):235-7. doi: 10.1097/00041433-200104000-00018. Curr Opin Lipidol. 2001. PMID: 11264995 No abstract available.

6

The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways.

Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, Sparks JD, Williams KJ. Fisher EA, et al. Among authors: williams kj. J Biol Chem. 2001 Jul 27;276(30):27855-63. doi: 10.1074/jbc.M008885200. Epub 2001 Apr 2. J Biol Chem. 2001. PMID: 11285257 Free article.

7

The level and species of plasma non-esterified fatty acids are not related to elevated plasma apolipoprotein B levels in familial combined hyperlipidemia.

Shamir R, Williams KJ, Cortner JL, Hudgins LC, Levine LC, McGee-Harper M, Fisher EA. Shamir R, et al. Among authors: williams kj. J Med. 2001;32(5-6):349-63. J Med. 2001. PMID: 11958280

8

Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.

Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA. Pan M, et al. Among authors: williams kj. J Clin Invest. 2004 May;113(9):1277-87. doi: 10.1172/JCI19197. J Clin Invest. 2004. PMID: 15124019 Free PMC article.

9

Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques.

Frias JC, Williams KJ, Fisher EA, Fayad ZA. Frias JC, et al. Among authors: williams kj. J Am Chem Soc. 2004 Dec 22;126(50):16316-7. doi: 10.1021/ja044911a. J Am Chem Soc. 2004. PMID: 15600321

10

Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?

Williams KJ, Fisher EA. Williams KJ, et al. Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):139-46. doi: 10.1097/00075197-200503000-00006. Curr Opin Clin Nutr Metab Care. 2005. PMID: 15716791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

649 results

Search Page

Filters